AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| ORR | Drilling Generates Further Mineralisation in Mauritania | PRICE SENSITIVE | 24/04/18 | |
| ORR | Change in substantial holding | 11/04/18 | ||
| ORR | Half Year Accounts | 13/03/18 | ||
| ORR | Acacia Press Release to LSE Dated 16 Feb 2018 | 19/02/18 | ||
| ORR Drilling Generates Further Mineralisation in Mauritania | |||
| 24/04/18 | PRICE SENSITIVE | ||
| ORR Change in substantial holding | |||
| 11/04/18 | |||
| ORR Half Year Accounts | |||
| 13/03/18 | |||
| ORR Acacia Press Release to LSE Dated 16 Feb 2018 | |||
| 19/02/18 | |||
